| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 49 |
| 1 | DOCETAXEL ANHYDROUS | 49 |
| 2 | TRASTUZUMAB | 34 |
| 3 | ADALIMUMAB | 25 |
| 4 | METHOTREXATE SODIUM | 24 |
| 5 | CARBOPLATIN | 23 |
| 6 | METHOTREXATE | 16 |
| 7 | PEGFILGRASTIM | 16 |
| 8 | PERTUZUMAB | 16 |
| 9 | DEXAMETHASONE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM CARBONATE ANTACID | 1 | 0.0130 |
| 1 | EPINASTINE HYDROCHLORIDE | 5 | 0.0044 |
| 2 | MEBENDAZOLE | 2 | 0.0025 |
| 3 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 4 | RITLECITINIB | 3 | 0.0015 |
| 5 | CYCLOPENTOLATE HYDROCHLORIDE | 1 | 0.0015 |
| 6 | MOGAMULIZUMAB-KPKC | 2 | 0.0015 |
| 7 | CLEMASTINE FUMARATE | 2 | 0.0014 |
| 8 | MEFENAMIC ACID | 3 | 0.0014 |
| 9 | PEGFILGRASTIM | 16 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 54 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 37 |
| 2 | Corticosteroid [EPC] | 34 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 34 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 5 | Platinum-based Drug [EPC] | 27 |
| 6 | Leukocyte Growth Factor [EPC] | 19 |
| 7 | Benzodiazepine [EPC] | 18 |
| 8 | beta-Adrenergic Blocker [EPC] | 17 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Anthelmintic [EPC] | 2 | 0.0007 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 5 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 34 | 0.0005 |
| 7 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 9 | Microtubule Inhibitor [EPC] | 54 | 0.0003 |